市場調査レポート

ハイコンテントスクリーニング (HCS) の世界市場

High Content Screening (HCS)

発行 Global Industry Analysts, Inc. 商品コード 248868
出版日 ページ情報 英文 202 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
ハイコンテントスクリーニング (HCS) の世界市場 High Content Screening (HCS)
出版日: 2016年02月01日 ページ情報: 英文 202 Pages
概要

当レポートでは、世界の世界のハイコンテントスクリーニング (HCS) 市場について調査し、2014年から2020年までの市場成長見通し、地域別動向、および市場に参入する主な企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 業界概要
    • HCS:発展するスクリーニング技術
    • 成長の機会のある市場
    • 主な市場成長促進因子
    • 主な課題
    • 市場見通し
    • 途上国が将来の成長を牽引
    • HCSソフト:高い成長市場
    • 装置売上は拡大しつづける
    • 医薬品業界の不況が消耗品および機器の見通しに打撃を与える
    • 競合概要
    • 市場の主な参入企業
    • ベンチャーキャピタル投資は増え続ける
  • 市場動向と課題
    • 主なスクリーニング法として発展
    • 技術進化が市場の成長を促進
    • 政府の支援が市場に好影響
    • HCSの主なユーザーとしての学術部門の登場
    • 幹細胞生物学:新興の関心領域
    • HCS特有のデータ解析システム
    • HCSとHTS
    • HTS試験所におけるHCS技術の導入拡大
    • 市場の課題
    • 装置コストの高さが成長を阻害
  • 製品概要
  • 製品イントロダクション/革新
  • 近年の業界活動
  • 主要企業
    • BD Biosciences
    • BioTek Instruments Inc.
    • Definiens AG
    • EMD Millipore
    • Evotec AG
    • Fluxion Biosciences, Inc.
    • GE Healthcare Life Sciences
    • Genedata AG
    • IntelliCyt Corporation
    • Molecular Devices Inc.
    • PerkinElmer Inc
    • Roche Applied Sciences
    • Thermo Fisher Scientific, Inc.
    • Thorlabs, Inc.
    • TTP LabTech Ltd.
    • 横河電機株式会社
  • 世界市場見通し

第3章 市場

  • 米国
  • 日本
  • カナダ
  • 欧州

第4章 競合環境

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MCP-6754

This report analyzes the worldwide markets for High Content Screening (HCS) in US$ Million. The Global market is further analyzed by the following Segments: Consumables, Instruments, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 73 companies including many key and niche players such as -

BD Biosciences
BioTek Instruments Inc.
Definiens AG
EMD Millipore
Evotec AG

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Consumables
    • Instrumentation
    • Others
      • Software
      • Services

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • HCS - An Evolving Screening Technology
  • HCS Market Ripe with Growth Opportunity
  • Key Growth Drivers
  • Key Challenges
  • Market Outlook
  • Developing Regions Drive Future Growth
    • Table 1: Global High Content Screening (HCS) Market - Geographic Regions Ranked by CAGR for 2014-2020 (includes corresponding Graph/Chart)
  • HCS Software - A High Growth Market
  • Equipment Sales Continue to Expand
  • Recession in Pharma Industry Hits Prospects for Consumables and Instruments
  • Competitive Overview
  • Focus on Key Players in the HCS Market
    • BD Biosciences
    • Thermo Fisher Scientific Inc.
    • GE Healthcare
    • PerkinElmer Inc.
    • Table 2: Leading Players in the Global HCS Market (2015E): Percentage Share Breakdown for BD Biosciences, GE Healthcare, PerkinElmer, Molecular Devices, Thermo Fisher Scientific, Thorlabs, and Others (includes corresponding Graph/Chart)
  • Venture Capital Investments Continue to Grow

2. MARKET TRENDS AND ISSUES

  • HCS - Evolves as Primary Screening Method
    • Table 3: Global Screening Market (2014): Percentage Share Breakdown by Segment - Primary Screening, Secondary Screening and Leads-to-Candidate (ADME/Tox Screening) (includes corresponding Graph/Chart)
  • Technology Advancements Spearhead Market Growth
  • Government Support Bodes Well for the Market
  • Emergence of Academic Sector as the Major User of HCS
    • Table 4: HCS Budget of a Typical Research Company (includes corresponding Graph/Chart)
    • Table 5: Global High-Throughput Screening Market (2015): Percentage Breakdown of Sales by End-use Segment (includes corresponding Graph/Chart)
  • Stem Cell Biology - An Emerging Area of Interest
  • HCS Specific Data Analysis Systems - The Need of the Hour
  • HCS vs. HTS
  • Rise in Adoption of HCS Technology in HTS Laboratories
  • Market Challenges
  • High Instrumentation Costs Hamper Rapid Growth

3. PRODUCT OVERVIEW

  • Defining High Content Screening
  • The Process of High Content Screening
  • The Process of High Content Screening
  • Technology Evolves Over the Years
  • HCS Tools
  • List of HCS Tools
  • HCS Imaging - Categories
  • Instrumentation
  • Consumables
  • Software
  • Services

4. PRODUCT INTRODUCTIONS/INNOVATIONS

  • Molecular Devices Launches New ImageXpressR Micro Confocal HCS
  • CYTOO Launches MyoScreenφ? Platform
  • Molecular Devices Unveils EarlyTox? Cell Viability Assay Kits
  • Molecular Devices Introduces FLIPRR Potassium Assay Kit
  • IntelliCyt Unveils iQueR Screener PLUS
  • BioTek Launches Cytation? 5 Cell Imaging Multi-Mode Reader
  • Genedata Launches Genedata ScreenerR 12
  • Thermo Fisher Scientific Introduces New CeLLInsight CX5 HCS Platform
  • PerkinElmer Introduces Opera Phenix? Next-Gen HCS System
  • Molecular Devices Unveils ImageXpressR Micro XLS System
  • TMO Unveils HCS Studio Software
  • Molecular Devices Launches FLIPRR Calcium 6 Assay Kits
  • TMO Expands its HCS Portfolio with Three New Products
  • Cytoo Introduces 2D+ Solutions
  • TTP Labtech Unveils Acumen High Content Imaging System

5. RECENT INDUSTRY ACTIVITY

  • Genedata Forms Alliance with IntelliCyt
  • Harlan Inks Strategic Partnership with Fluofarma
  • BioTech Inks Distribution Agreement with IDEA Bio-Medical

6. FOCUS ON SELECT GLOBAL PLAYERS

  • BD Biosciences (US)
  • BioTek Instruments Inc. (US)
  • Definiens AG (Germany)
  • EMD Millipore (US)
  • Evotec AG (Germany)
  • Essen BioScience (US)
  • Fluxion Biosciences, Inc. (US)
  • GE Healthcare Life Sciences (Sweden)
  • Genedata AG (Switzerland)
  • IntelliCyt Corporation (US)
  • Molecular Devices Inc. (US)
  • PerkinElmer Inc. (US)
  • Roche Applied Sciences (Germany)
  • Thermo Fisher Scientific, Inc. (US)
  • Thorlabs, Inc. (US)
  • TTP LabTech Ltd. (UK)
  • Yokogawa Electric Corporation (Japan)

7. GLOBAL MARKET PERSPECTIVE

    • Table 6: World Recent Past, Current & Future Analysis for High Content Screening by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 7: World Historic Review for High Content Screening by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 8: World 14-Year Perspective for High Content Screening by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 9: World Recent Past, Current & Future Analysis for High Content Screening by Segment - Consumables, Instruments, and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 10: World Historic Review for High Content Screening by Segment - Consumables, Instruments, and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 11: World 14-Year Perspective for High Content Screening by Segment - Percentage Breakdown of Revenues for Consumables, Instruments, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Market Overview
    • Product Launches
    • Recent Industry Activity
    • Key Players
  • B. Market Analytics
    • Table 12: US Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 13: US Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analysis
    • Table 14: Canadian Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 15: Canadian Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Outlook
    • Yokogawa Electric Corporation - A Key Player
  • B. Market Analytics
    • Table 16: Japanese Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 17: Japanese Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Clinical Trials Market in Europe
  • B. Market Analytics
    • Table 18: European Recent Past, Current & Future Analysis for High Content Screening by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 19: European Historic Review for High Content Screening by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 20: European 14-Year Perspective for High Content Screening by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Outlook
    • Corporate Development
    • Fluofarma SA - A Key Player
  • B. Market Analytics
    • Table 21: French Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 22: French Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Outlook
    • Key Players
  • B. Market Analytics
    • Table 23: German Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 24: German Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Outlook
  • B. Market Analytics
    • Table 25: Italian Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 26: Italian Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Outlook
    • Product Launch
    • Key Players
  • B. Market Analytics
    • Table 27: The UK Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 28: The UK Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Outlook
  • B. Market Analytics
    • Table 29: Spanish Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 30: Spanish Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4f. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Product Launch
    • Strategic Corporate Development
    • Key Players
  • B. Market Analytics
    • Table 31: Rest of Europe Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 32: Rest of Europe Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Select Regional Analysis
      • China
      • China Emerges as the Major Outsourcer for Drug Discovery
      • India
  • B. Market Analytics
    • Table 33: Asia-Pacific Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 34: Asia-Pacific Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • Market Analysis
    • Table 35: Rest of World Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 36: Rest of World Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top